These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24768378)

  • 1. Risk of cardiovascular disease in patients on thrice-weekly versus twice-weekly hemodialysis.
    Cheng Y; Tu W; Xiao Q; Chen Y; Hu L; Wu X
    Int J Cardiol; 2014 Jul; 174(3):780-3. PubMed ID: 24768378
    [No Abstract]   [Full Text] [Related]  

  • 2. Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: a prospective cohort study.
    Panaput T; Thinkhamrop B; Domrongkitchaiporn S; Sirivongs D; Praderm L; Anukulanantachai J; Kanokkantapong C; Tungkasereerak P; Pongskul C; Anutrakulchai S; Keobounma T; Narenpitak S; Intarawongchot P; Suwattanasin A; Tatiyanupanwong S; Niwattayakul K
    Blood Purif; 2014; 38(3-4):253-62. PubMed ID: 25573488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients.
    Weinhandl ED; Nieman KM; Gilbertson DT; Collins AJ
    Am J Kidney Dis; 2015 Jan; 65(1):98-108. PubMed ID: 25085647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional status of twice and thrice-weekly hemodialysis patients with weekly Kt/V > 3.6.
    Supasyndh O; Satirapoj B; Seenamngoen S; Yongsiri S; Choovichian P; Vanichakarn S
    J Med Assoc Thai; 2009 May; 92(5):624-31. PubMed ID: 19459522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of intradialytic hypotension in patients on thrice-weekly versus twice-weekly hemodialysis.
    Lei G; Li X; Tu W; Xu C; Duan Z; Wu X
    Int J Cardiol; 2014 Jul; 174(3):821-3. PubMed ID: 24801088
    [No Abstract]   [Full Text] [Related]  

  • 6. Once-weekly hemodialysis combined with low-protein and low-salt dietary treatment as a favorable therapeutic modality for selected patients with end-stage renal failure: a prospective observational study in Japanese patients.
    Nakao T; Kanazawa Y; Takahashi T
    BMC Nephrol; 2018 Jun; 19(1):151. PubMed ID: 29954331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous alfacalcidol once versus twice or thrice weekly in hemodialysis patients.
    Alghareeb A; Sabry A; Bawadekji H; Alsaran K
    Ther Apher Dial; 2013 Feb; 17(1):30-4. PubMed ID: 23379490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, infection and cardiovascular events in chronic hemodialysis patients: a prospective study.
    Bellomo G; Lippi G; Saronio P; Reboldi G; Verdura C; Timio F; Timio M
    J Nephrol; 2003; 16(2):245-51. PubMed ID: 12768072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of twice-weekly hemodialysis patients in shanghai.
    Lin X; Yan Y; Ni Z; Gu L; Zhu M; Dai H; Zhang W; Qian J
    Blood Purif; 2012; 33(1-3):66-72. PubMed ID: 22212562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
    Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease: the new silent killer.
    Kopyt NP
    J Am Osteopath Assoc; 2006 Mar; 106(3):133-6. PubMed ID: 16585380
    [No Abstract]   [Full Text] [Related]  

  • 12. Time-dependent effect of sevelamerHCl on the cardiovascular system.
    Savica V; Monardo P; Santoro D; Mallamace A; Bellinghieri G
    Nephrol Dial Transplant; 2008 Jun; 23(6):2102-3; author reply 2103. PubMed ID: 18353887
    [No Abstract]   [Full Text] [Related]  

  • 13. [Morbidity in hemodialysis].
    Galindo P; Martínez Sánchez T; Osuna A; Asensio C
    Nefrologia; 2002; 22(2):202-3. PubMed ID: 12085423
    [No Abstract]   [Full Text] [Related]  

  • 14. Inadequate treatment of cardiovascular disease and cardiovascular disease risk factors in dialysis patients: a commentary.
    Culleton BF; Hemmelgarn B
    Semin Dial; 2004; 17(5):342-5. PubMed ID: 15461738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental Hemodialysis: The University of California Irvine Experience.
    Ghahremani-Ghajar M; Rojas-Bautista V; Lau WL; Pahl M; Hernandez M; Jin A; Reddy U; Chou J; Obi Y; Kalantar-Zadeh K; Rhee CM
    Semin Dial; 2017 May; 30(3):262-269. PubMed ID: 28295607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaching target hemoglobin level and having a functioning arteriovenous fistula significantly improve one year survival in twice weekly hemodialysis.
    Elamin S; Abu-Aisha H
    Arab J Nephrol Transplant; 2012 May; 5(2):81-6. PubMed ID: 22612193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity and mortality on maintenance haemodialysis.
    Locatelli F; Del Vecchio L; Manzoni C
    Contrib Nephrol; 1998; 124():166-89; discussion 190-201. PubMed ID: 9761980
    [No Abstract]   [Full Text] [Related]  

  • 20. Twice-Weekly Hemodialysis in China: Can It Be A Better Option for Initiation or Maintenance Dialysis Therapy?
    Yan Y; Ramirez S; Anand S; Qian J; Zuo L
    Semin Dial; 2017 May; 30(3):277-281. PubMed ID: 28345136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.